Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 59th Annual Scientific Session of the American College of Cardiology
New Treatment Strategies for CABG Patients with Acute Coronary Syndrome
Atlanta, Georgia / March 14-16, 2010
Atlanta - In patients with acute coronary syndromes (ACS), new data re-emphasize that an emerging generation of more potent antiplatelet agents are reducing major vascular events relative to clopidogrel. In a new analysis presented here at...
PRIORITY PRESS - 59th Annual Scientific Session of the American College of Cardiology
Advances in Dyslipidemia Management: Extending the Clinical Benefit
Atlanta, Georgia / March 14-16, 2010
Atlanta - A statin has been licensed for reduction of cardiovascular (CV) risk in patients without a traditionally defined elevation in LDL-C. The newly released indication was similarly defined by both Health Canada and the U.S. Food and...
MEDICAL FRONTIERS - 59th Annual Scientific Session of the American College of Cardiology (ACC)
Emerging Antiplatelet Strategies in Acute Coronary Syndromes: Focus on the CABG Population
Atlanta, Georgia / March 14-16, 2010
Atlanta - In patients with acute coronary syndromes (ACS), new data re-emphasize that an emerging generation of more potent antiplatelet agents are reducing major vascular events relative to clopidogrel. In a new analysis presented here at...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the First Systemic Sclerosis World Congress
Focus on Systemic Sclerosis Patients For Early Diagnosis and Treatment of Pulmonary Arterial Hypertension
Florence, Italy / February 11-13, 2010
INTRODUCTION Systemic sclerosis (SSc) is a multi-system connective tissue disease characterized by excessive fibrosis, inflammation and vasculopathy; it affects both the skin and internal organs. A devastating complication of SSc is...
MEDI-NEWS
Angiotensin II Receptor Blocker Review
November 2009
Based on the following articles: Verdecchia et al. Comparative assessment of angiotensin receptor blockers in different clinical settings. Vasc Health Risk Manag 2009;5:939-48. Kjeldsen et al. Effects of losartan vs candesartan in reducing...
PRIORITY PRESS - 82nd Scientific Sessions of the American Heart Association
Surrogate End Point Study in Stable Cardiovascular Disease Encourages Raising HDL in Addition to LDL Lowering
Orlando, Florida / November 14-18, 2009
Orlando - According to a study discussed here this week, raising the HDL level was associated with a regression in carotid intima media thickness (CIMT) in patients with cardiovascular disease who already have relatively low plasma levels...
MEDICAL FRONTIERS - 82nd Scientific Sessions of the American Heart Association
New Data on Antiplatelet Therapies in ACS Predict Rapid Evolution in Clinical Practice
Orlando, Florida / November 14-18, 2009
Orlando - Two new strategies promise to reduce the risk of thrombotic events in patients with an acute coronary syndrome. One involves new antiplatelet agents associated with greater and more consistent platelet inhibition than clopidogrel,...
PRIORITY PRESS - Canadian Cardiovascular Congress 2009
New Canadian Cholesterol Guidelines: Lower Targets, New Risk Markers
Edmonton, Alberta / October 24-28, 2009
Edmonton - The Canadian cholesterol guidelines for lipid lowering were recently modified to recommend the same treatment goals in patients at intermediate risk as patients at high risk. In both, the LDL target has been defined as <2.0...
PRIORITY PRESS - Canadian Cardiovascular Congress 2009
Simplified Strategies for Efficient Treatment of Elevated LDL
Edmonton, Alberta / October 24-28, 2009
Edmonton - A large multicentre study conducted in a family practice setting has demonstrated that patients with diabetes can be brought to the currently recommended goal for LDL with an adequate starting dose or a single upwards titration....